The Effect of Reflexology in Patients With Viral Bronchiolitis
Sponsor
Hillel Yaffe Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT05799677
Collaborator
(none)
30
1
2
2.9
10.3
Study Details
Study Description
Brief Summary
To test the influence of reflexology on bronchiolitis.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Reflexology has been used in different respiratory tract infections on pulmonary function tests in patients with asthma, with some success. It has also been tested in newborns with respiratory distress syndrome, where it has decreased respiratory rate. Whole body massage was found to be helpful in newborns with opioid withdrawal syndrome. It has been shown to be a safe treatment and well tolerated even among very young infants.
Therefore, the investigators decided to evaluate effect of reflexology treatment in patients with viral bronchiolitis.
Study Design
Study Type:
Interventional
Actual Enrollment
:
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Comparing the extent of bronchiolitis between reflexology additive treatment to no reflexology treatment.Comparing the extent of bronchiolitis between reflexology additive treatment to no reflexology treatment.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Reflexology in Patients With Viral Bronchiolitis
Actual Study Start Date
:
Jan 1, 2023
Actual Primary Completion Date
:
Mar 31, 2023
Actual Study Completion Date
:
Mar 31, 2023
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Reflexology Additive treatment with reflexology |
Other: Reflexology
Additive reflexology treatment
|
| No Intervention: Control No treatment with reflexology |
Outcome Measures
Primary Outcome Measures
- Hospitalization period [1-14 days]
The time from admission to discharge (days)
- Oxygen therapy period [1-14 Days]
Number of days of oxygen treatment
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- All children admitted due to bronchiolitis
Exclusion Criteria:
- Children whose parents refused participation
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Hillel Yaffe medical center | H̀±adera | Hadera | Israel | 38100 |
Sponsors and Collaborators
- Hillel Yaffe Medical Center
Investigators
- Principal Investigator: Erez Nadir, MD, Hillel Yaffe Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
- Fattah MA, Hamdy B. Pulmonary functions of children with asthma improve following massage therapy. J Altern Complement Med. 2011 Nov;17(11):1065-8. doi: 10.1089/acm.2010.0758.
- Jones LM, Regan C, Wolf K, Bryant J, Rakowsky A, Pe M, Snyder DA. Effect of osteopathic manipulative treatment on pulmonary function testing in children with asthma. J Osteopath Med. 2021 May 7;121(6):589-596. doi: 10.1515/jom-2020-0040.
- Miralizadeh A, Peyman A, Jamali Soltani N, Ashktorab T. Comparison of the Effect of Foot and Palm Reflexology Massage on Respiratory Distress Syndrome in Premature Infants under Noninvasive Ventilation. Complement Med Res. 2022;29(2):100-108. doi: 10.1159/000517982. Epub 2021 Oct 29.
- Rana D, Garde K, Elabiad MT, Pourcyrous M. Whole body massage for newborns: A report on non-invasive methodology for neonatal opioid withdrawal syndrome. J Neonatal Perinatal Med. 2022;15(3):559-565. doi: 10.3233/NPM-220989.
- Roque i Figuls M, Gine-Garriga M, Granados Rugeles C, Perrotta C, Vilaro J. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2016 Feb 1;2(2):CD004873. doi: 10.1002/14651858.CD004873.pub5.
- Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis. 1992 Jan;145(1):106-9. doi: 10.1164/ajrccm/145.1.106.
Responsible Party:
Erez Nadir, MD,
Principal Investigator,
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT05799677
Other Study ID Numbers:
- 0135-22-HYMC-IL
First Posted:
Apr 5, 2023
Last Update Posted:
Apr 11, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Erez Nadir, MD,
Principal Investigator,
Hillel Yaffe Medical Center
Additional relevant MeSH terms: